Asymmetric Dimethyl-SMARCC1/BAF155 (Arg1)

The University of Nebraska Medical Center, a state agency in Nebraska, awarded a purchase order contract to Cell Signaling Technology Inc., a Boston, Massachusetts-based vendor, for the procurement of one unit of Asymmetric Dimethyl-SMARCC1/BAF155 (Arg1), a specialized research reagent identified by material number 94962S. The contract, issued March 4, 2026, carries a total value of $482.00 and specifies delivery to the University of Nebraska Medical Center's facility located at 601 Saddle Creek Road, Omaha, Nebraska by March 18, 2026.

Performance is governed by the Standard Terms of Purchase established by the University of Nebraska Board of Regents, with delivery terms specified as Free on Board destination with freight prepaid. Payment will be rendered by the Nebraska State Treasury warrant under Net 30 terms. The vendor is required to acknowledge acceptance of the purchase order within ten days of issuance and to include packing slips with all shipments while displaying the purchase order number 4800184216 on packages, invoices, and related documentation to facilitate timely payment processing.